The Clay Travis and Buck Sexton Show — Wellness Unmasked Weekly Rundown

Episode Title: Measles Cases Surge in the U.S., Vaccine Debate Returns & FDA Warns on GLP-1 Weight Loss Drugs
Host: Dr. Nicole Saphier
Date: March 5, 2026

Episode Overview

This episode of The Clay Travis and Buck Sexton Show’s “Wellness Unmasked Weekly Rundown” is hosted by Dr. Nicole Saphier. The main focus is America’s alarming surge in measles cases—putting the country’s long-held elimination status at risk—and the broader resurgence of vaccine skepticism and debate. Dr. Saphier also covers FDA warnings concerning compounded GLP-1 weight loss drugs, emphasizing the importance of science-based, transparent health information, and candidly addresses the risks and benefits of vaccines in the wake of public health trust issues.

Key Discussion Points & Insights

1. Measles Outbreaks: A Public Health Alarm

• [02:35] - [06:35]
  • Dr. Saphier voices fatigue over repeated measles discussions, highlighting that cases are rising rapidly: over 1,000 cases in early 2026, outbreaks in multiple states, and the highest infection rates in more than 30 years.
  • Measles elimination (achieved in 2000) is threatened, with entire states seeing cases after years of absence.
  • Measles’ extreme contagiousness: "If one infected person enters a room of unvaccinated people, about 9 out of 10 can become infected." (03:52)
  • International travel can easily seed new outbreaks.

2. CDC Response and Messaging Shift

• [04:20]
  • Dr. Jay Bhattacharya, newly acting CDC director under the Trump administration, releases strong pro-vaccination messaging.
  • Dr. Saphier supports this change: "I'll be honest, I'm here for it. I love the new messaging." (04:34)

3. MMR Vaccination: Science, History, and Community Protection

• [04:40] - [05:50]
  • Vaccines are highly effective: "The MMR vaccine... it's about 97% effective at preventing disease after two doses." (04:52)
  • Dr. Saphier explains herd immunity benefits—protecting infants, pregnant women, and immune-compromised individuals.
  • “History shows the impact. Before the measles vaccine was introduced in 1963, millions of Americans were infected each year and hundreds died annually.” (05:05)
  • Measles complications extend far beyond death: includes permanent brain damage and costly hospitalizations.

4. Vaccines, Trust, and Risk: Post-COVID Reflections

• [05:55] - [07:25]
  • Public hesitation stems from vaccine mandates, politicization, and COVID-era policy missteps.
  • Dr. Saphier’s dual perspective:
    1. "Patients deserve the freedom to make medical decisions with their doctor."
    2. "They also deserve honest, transparent information about what the science actually shows." (06:25)
  • Acknowledges rare but real vaccine side effects but stresses that benefits greatly outweigh risks: “When vaccination rates drop, preventable diseases come back. And measles is one of the clearest examples of that.” (07:04)
  • Vaccination rates have declined, especially post-COVID.

5. Urgency to Restore Public Health Confidence

• [07:10]
  • Calls for ending excessive mandates, improving messaging, and emphasizing vaccines’ safety and efficacy.
  • “We need to roll back a lot of the mand[ates], but we also need to make sure that there is clear messaging that vaccines, while they come with risks, are overwhelmingly safe.” (07:14)

6. FDA Crackdown on Compounded GLP-1 Weight Loss Drugs

• [07:30] - [08:56]
  • The FDA recently warned over 30 telehealth companies making misleading claims about compounded GLP-1 medications (like semaglutide).
  • Dr. Saphier: “The FDA is saying, I don't think so. We don't believe that they have been safety and quality tested. They are not equivalent.” (08:07)
  • FDA-approved products undergo rigorous safety and quality checks, unlike compounded versions from medspas or online sellers.
  • Since the rollout of TrumpRx, FDA-approved GLP-1s are more accessible and affordable, lessening the need for compounded alternatives.
  • Bottom line: “Talk to your doctor before you take any of these medications. ... The FDA approved ones are going to be safer because they have been quality tested.” (08:43)

7. Guiding Philosophy: Science, Transparency, Responsibility

• [08:56] - [09:41]
  • Calls for a balance of transparency, responsibility, and science in public health messaging, rather than top-down control.
  • “The goal isn’t control, it’s protection. Protection for our families, our communities and the most vulnerable amongst us.” (09:23)

Notable Quotes & Memorable Moments

• On Measles Elimination Risks:

  • “We’ve gone a quarter of a century with the elimination status of measles... but that status, it’s now at risk.”
    — Dr. Nicole Saphier (03:02)

• On Contagiousness:

  • “If one infected person enters a room of unvaccinated people, about 9 out of 10 can become infected. And it sticks around for a while.”
    — Dr. Nicole Saphier (03:52)

• On Vaccine Imperfects and Realism:

  • “No medical intervention is perfect. I talk with patients every single day about the risks and benefits... Vaccines are no different.”
    — Dr. Nicole Saphier (06:41)

• On GLP-1 Medication Safety:

  • “FDA approved medications go through rigorous testing for safety dosing and manufacturing standards. Compounding medications... are not the same as an approved drug.”
    — Dr. Nicole Saphier (08:13)

• On the Role of Public Health:

  • “Public health works best when science, transparency, and personal responsibility all work together.”
    — Dr. Nicole Saphier (09:18)

Timestamps for Key Segments

• [02:35] Measles cases surging — 1,000+ reports, outbreaks in multiple states
• [03:52] Measles’ extreme infectiousness explained
• [04:20] CDC messaging shift; new director Jay Bhattacharya
• [04:40] Efficacy of MMR vaccine and protection for the community
• [05:05] History of measles and vaccine-preventable complications
• [06:25] Dr. Saphier’s dual approach: freedom and transparency
• [07:04] Connection between declining vaccination rates and outbreaks
• [07:30] FDA warning on compounded GLP-1 drugs
• [08:43] Medical advice: FDA-approved vs. compounded drugs
• [09:18] Final thoughts: science, transparency, responsibility in public health

Takeaway

Dr. Nicole Saphier delivers a clear-eyed, balanced perspective on the urgency of maintaining high vaccination rates to prevent large-scale disease return. She addresses the challenges of vaccine hesitancy post-COVID and calls for both transparency and liberty in healthcare decisions. On weight loss medications, she cautions listeners about non-FDA-approved compounded drugs. Her guiding message is a plea for public health grounded in science, honesty, and shared responsibility—not control.